-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCKET PHARMACEUTICALS ANNOUNCES POSITIVE CLINICAL SAFETY UPDATE FROM INITIAL THREE PATIENTS TREATED WITH RP-A501 UNDER MODIFIED PHASE 2 PROTOCOL FOR DANON DISEASE

Reuters·08/03/2026 11:00:02

Please log in to view news